The BeLimumab Antiphospholipid Syndrome Trial (BLAST)
Clinical trial NCT05020782 · UNKNOWN
Trial details
- NCT number
- NCT05020782
- Sponsor
- University of Turin, Italy
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2024-10-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.